Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/11/2010US7713692 Nucleic-acid probe substrate, system for temperature control of the substrate, and gene detection method making use of the same
05/11/2010US7713691 Modified nucleic acid polymers and methods for their production
05/11/2010US7713531 Protein, a gene encoding therefor and a method of using the same
05/11/2010US7713530 HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713522 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis
05/11/2010CA2533440C Amplifying atp with adp-free polyphosphate-adenylate kinase fusion protein
05/11/2010CA2527225C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
05/11/2010CA2409674C Glutamic acid decarboxylase (gad) based delivery systems
05/11/2010CA2392722C Male tissue-preferred regulatory region and method of using same
05/11/2010CA2366914C Enhanced system for construction of adenovirus vectors
05/11/2010CA2366231C One step sample preparation and detection of nucleic acids in complex biological samples
05/11/2010CA2362550C Antibody fragment-targeted immunoliposomes for systemic gene delivery
05/11/2010CA2341638C Use of a midkine inhibitor
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2330735C Fy7 polymerase
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318887C Methods and compositions for modifying levels of secondary metabolic compounds in plants
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/11/2010CA2268860C Leaf-specific gene expression in transgenetic plants
05/11/2010CA2254866C Methods for creating transgenic animals
05/11/2010CA2205237C Pesticidal composition comprising cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/11/2010CA2180965C Influenza vaccine
05/11/2010CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/11/2010CA2140637C Genetic sequences encoding glycosyltransferase enzymes and uses therefor
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/06/2010WO2010051533A2 Compositions of engineered human arginases and methods for treating cancer
05/06/2010WO2010051521A1 Cell therapy product for the treatment of hiv infection
05/06/2010WO2010051502A2 Light targeting molecules and uses thereof
05/06/2010WO2010051329A2 Device for controlling the flow of anesthetic from a reservoir
05/06/2010WO2010051310A2 ANTI-TNFα FIBRONECTIN TYPE III DOMAIN BASED SCAFFOLD COMPOSITIONS, METHODS AND USES
05/06/2010WO2010051204A2 Bcr-abl variants
05/06/2010WO2010051049A2 Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
05/06/2010WO2010050997A1 Method for adenoviral vector synthesis
05/06/2010WO2010050903A1 Chimeric flagellins for vaccines
05/06/2010WO2010050902A1 Vaccines, which combine the antigen and toll-like receptors
05/06/2010WO2010050829A1 Marker assisted selection of a mammalian subject for desired immunoglobulin phenotype
05/06/2010WO2010050801A1 Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
05/06/2010WO2010050626A1 Method for producing induced pluripotent stem cells
05/06/2010WO2010050605A1 Cinerarium-derived chromosomal dna involved in synthesis of flavonoid, and use thereof
05/06/2010WO2010050586A1 Method for enhancing expression of recombinant protein
05/06/2010WO2010050585A1 Vector for treating alzheimer's disease
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050554A1 Immunoassay method for human cxcl1 protein
05/06/2010WO2010050528A1 Anti-muc1 antibody
05/06/2010WO2010050516A1 Method for producing l-amino acid
05/06/2010WO2010050470A1 Process for producing polylactic acid using genetically modified bacterium
05/06/2010WO2010050418A1 Mutant reverse transcription dna polymerase
05/06/2010WO2010050328A1 Tumor metastasis inhibitor
05/06/2010WO2010050268A1 Molecular marker for cancer stem cell
05/06/2010WO2010050231A1 Scyllo-inositol-producing cell and scyllo-inositol production method using said cells
05/06/2010WO2010050190A1 Molecular marker for cancer stem cell
05/06/2010WO2010050109A1 Kit for producing double-stranded rna with lactic acid bacterium, and use thereof
05/06/2010WO2010049933A1 Efficient expression of truncated human rnaset2 in e. coli
05/06/2010WO2010049817A2 Lipochito-oligosaccharides stimulating arbuscular mycorrhizal symbiosis
05/06/2010WO2010049807A2 Method for recombinant expression of polypeptides
05/06/2010WO2010049777A1 An expression vector and processes thereof
05/06/2010WO2010049571A1 Procedure for the obtainment of mannoprotein-superproducing wine yeasts by non-recombinant technologies
05/06/2010WO2010049494A1 Them5- modified models of non-alcoholic fatty liver disease
05/06/2010WO2010049375A1 Use of bacteria for the sensing and killing of cancer cells
05/06/2010WO2010049177A1 Novel tools for the production of glycosylated proteins in host cells
05/06/2010WO2010049173A1 Use of inhibitors of host kinases for the treatment of infectious diseases
05/06/2010WO2010048666A1 Transcriptional control elements and uses therefor - ii
05/06/2010WO2010033818A8 Mirna targets
05/06/2010WO2010030976A3 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
05/06/2010WO2010029357A3 Method for the alteration of plants using cle polypeptides / peptides
05/06/2010WO2010026219A3 New tomato ethylene response factors and uses thereof
05/06/2010WO2010026169A3 Method for isolating and purifying nucleic acids
05/06/2010WO2010023658A3 Compositions and methods for the treatment of glioblastoma
05/06/2010WO2010023310A3 The an3 protein complex and its use for plant growth promotion
05/06/2010WO2010021849A3 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae
05/06/2010WO2010021846A3 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae
05/06/2010WO2010017653A8 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
05/06/2010WO2010016067A3 Affinity purification by cohesin-dockerin interaction
05/06/2010WO2010014975A3 Use of microrna signatures for assessing risk levels of neuroblastoma patients
05/06/2010WO2010014949A3 Compositions comprising hepatocyte-like cells and uses thereof
05/06/2010WO2010014922A3 Protein purification tags and uses thereof
05/06/2010WO2010014740A3 Eg82013 and eg81345 nucleic acids and uses thereof
05/06/2010WO2010011884A3 Novel nucleic acid-based molecular probes
05/06/2010WO2010006136A3 Adenovirus targeting
05/06/2010WO2010002160A9 Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
05/06/2010WO2009155464A3 Mutated and chemically modified thermally stable dna polymerases
05/06/2010WO2009152346A3 Compositions comprising phosphoinositide 3-kinase sirna and methods of use thereof
05/06/2010WO2009145945A3 Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldarius and related organisms
05/06/2010WO2009139630A9 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
05/06/2010WO2009134452A3 Preterm delivery diagnostic assay
05/06/2010WO2009132220A9 Isoprene synthase variants for improved microbial production of isoprene
05/06/2010WO2009130291A3 Plant seed oil
05/06/2010WO2009129319A3 Silencing of csn5 gene expression using interfering rna
05/06/2010WO2009095719A3 Use of crac inhibitors and cysteinyl leukotriene inhibitors for treating allergy and asthma
05/06/2010WO2009086156A3 Mir-10 regulated genes and pathways as targets for therapeutic intervention
05/06/2010WO2009047360A9 Il-21 antibodies
05/06/2010WO2006094084A3 Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
05/06/2010US20100115667 Novel At1g67330 gene involved in altered nitrate uptake efficiency
05/06/2010US20100115666 Transcriptional Repressors of Cytokinin Signaling and Their Use
05/06/2010US20100115664 Use of Trehalase Genes to Confer Nematode Resistance to Plants
05/06/2010US20100115662 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
05/06/2010US20100115661 Methods and compositions for the modulation of amino acid biosynthesis
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 4023